Startups
HeartBeat.bio is a recently founded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies. Our core technology is based on the world-wide first, self-organizing cardiac organoids (Cardioids) which resemble the human physiology of a human heart chamber in a way that allows for the cost-efficient and large scale in-vitro analysis of crucial clinical parameters associated with various cardiac diseases. The Cardioid-based screening platform has the potential to radically change the current cardiovascular drug discovery paradigm.
Overview
Location
Austria, Vienna
Employees
11-50
Total raised
$6.63M
Founded date
2021
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 4, 2021 | Seed round | $1.8M |
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 2, 2025 | 10 fast-growing Austrian startups to watch closely in 2025 | Austria has become an increasingly important player in Europe’s startup scene, with a rapidly growing ecosystem that blends innovation, investment, and talent. Austria’s capital city, Vienna, is home to nearly half of the country’s startups... |
| Nov 3, 2023 | Wefox erhält 55 Millionen – Agile Robots kauft Franka Emika – Via übernimmt Clevershuttle | Im #DealMonitor für den 3. November werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-... |
| Nov 3, 2023 | Austrian biotech HeartBeat.bio raises €4.5M pre-Series A round | Austrian biotech HeartBeat.bio raises €4.5M pre-Series A round 03 November, 2023, 11:04 Rostyslav Sobachynskyi --> --> --> -->--> --> --> --> --> --> --> --> --> Austrian biotech startup HeartBeat.b... |
| Nov 3, 2023 | Vienna-based HeartBeat.bio raises €4.5 million to develop 3D human tissue-based drug discovery platform for heart disease | |
| Nov 3, 2023 | HeartBeat.bio Closes € 4.5M Pre-Series A Funding Round | HeartBeat.bio, a Vienna, Austria-based biotech company providing a human organoid and AI-supported drug discovery platform for heart disease, raised €4.5M in Pre-Series A funding. The round was led by i&i Biotech Fund, Invest AG, aws Gr... |
| Nov 2, 2023 | Austrian biotech HeartBeat.bio secures €4.5M for cardioid drug discovery platform | Austrian biotech startup HeartBeat.bio has secured a € 4.5 million Pre-Series A round. The fresh capital will fuel the completion of its cardioid drug discovery platform for proprietary and collaborative drug discovery programs for the like... |
| Sep 12, 2022 | Molecular Devices and HeartBeat.bio announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery | Cardioid imaged on ImageXpress® Micro Confocal High-Content Imaging System As Cardioids represent better predictive models than cardiomyocytes or engineered spheroid models, this collaboration has the potential to considerably improve precl... |
| May 20, 2021 | PRESS RELEASE : HeartBeat.bio announces publication in Cell demonstrating the power of human heart organoids | DGAP-News: HeartBeat.bio AG / Key word(s): Scientific publication HeartBeat.bio announces publication in Cell demonstrating the power of human heart organoids 2021-05-20 / 17:00 The issuer is solely responsible for the content of this annou... |
| May 20, 2021 | HeartBeat bio : announces publication in Cell demonstrating the power of human heart organoids | DGAP-News: HeartBeat.bio AG / Key word(s): Scientific publication HeartBeat.bio announces publication in Cell demonstrating the power of human heart organoids 20.05.2021 / 17:00 The issuer is solely responsible for the content of this annou... |
Show more
Reviews 0
FAQ about HeartBeat.bio AG
When was HeartBeat.bio AG founded?
HeartBeat.bio AG was founded in 2021.
How much funding has HeartBeat.bio AG raised?
HeartBeat.bio AG has raised $6.63M in total across 2 funding rounds.
What funding rounds has HeartBeat.bio AG raised?
Parsers VC lists 2 funding rounds of HeartBeat.bio AG, among them a seed round of $1.8M on May 4, 2021.
What has the press written about HeartBeat.bio AG?
Parsers VC has collected 12 articles mentioning HeartBeat.bio AG, among them “10 fast-growing Austrian startups to watch closely in 2025” (Jan 2, 2025) and “Wefox erhält 55 Millionen – Agile Robots kauft Franka Emika – Via übernimmt Clevershuttle” (Nov 3, 2023).
Is HeartBeat.bio AG still active?
Yes, HeartBeat.bio AG is active; its latest activity on Parsers VC dates from Aug 10, 2026.